Analysts' Top Healthcare Picks: NewAmsterdam Pharma Company (NAMS), Elanco Animal Health (ELAN)
Johnson & Johnson Analyst Ratings
Johnson & Johnson (JNJ) Receives a Buy From RBC Capital
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cytek Biosciences (CTKB), Elanco Animal Health (ELAN) and Atara Biotherapeutics (ATRA)
Eli Lilly and Co Analyst Ratings
Argus Adjusts Price Target on Eli Lilly to $840 From $770
Redburn Atlantic Adjusts Eli Lilly Price Target to $600 From $540
Wells Fargo Reaffirms Their Hold Rating on Bristol-Myers Squibb (BMY)
Elanco Animal Health Analyst Ratings
Piper Sandler Remains a Hold on Elanco Animal Health (ELAN)
Redburn Atlantic Adjusts Price Target on Pfizer to $27 From $26, Keeps Neutral Rating
Bank of America Securities Keeps Their Buy Rating on Royalty Pharma (RPRX)
Catalent's Resilient Growth and Positive Outlook Reinforce Buy Rating
Elanco Animal Health Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), IGM Biosciences (IGMS) and Elanco Animal Health (ELAN)
RBC Capital Sticks to Their Hold Rating for Catalent (CTLT)
Analysts' Top Healthcare Picks: Elanco Animal Health (ELAN), Syndax Pharmaceuticals (SNDX)
HSBC Maintains Buy on Zoetis, Lowers Price Target to $225
Zoetis Analyst Ratings
China Merchants Initiates Eli Lilly at Buy Rating With $852 Price Target